We’re pleased to announce that Sébastien Tabruyn, CEO of TransCure bioServices, will attend the 25th Annual Biotech in Europe Forum (SACHS) on October 8–9, 2025, in Basel, Switzerland.
Bringing together key decision-makers from biotech, pharma, and finance, the SACHS Biotech in Europe Forum is a prime opportunity to foster new partnerships, explore funding opportunities, and connect with innovation drivers across the life sciences sector.
As a CRO specializing in preclinical studies using humanized mouse models, TransCure bioServices offers advanced translational platforms to support research in oncology, inflammation, and liver diseases.